NCT00094991已完成3 期
Mechanism of Action and Efficacy of Muraglitazar (BMS298585) in the Treatment of Type 2 Diabetic Patients
Bristol-Myers Squibb2 个研究点 分布在 2 个国家目标入组 42 人开始时间: 2004年5月最近更新:
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 42
- 试验地点
- 2
- 主要终点
- The change from baseline in insulin medicated glucose disposal after 16 weeks of treatment with Muraglitazar
研究概览
简要总结
The purpose of this study is to learn more about how muraglitazar lowers blood sugar in people with type 2 diabetes. The safety of this treatment will also be studied.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Type 2 diabetes;
- •Serum triglyceride concentration < or = 600 mg/dL;
- •Body mass index < or = 37 kg/m2
排除标准
- •Type 1 diabetes;
- •History of myocardial infarction (MI), coronary angioplasty, bypass graft(s), valvular disease, unstable angina pectoris, transient ischemic attack (TIA), or cerebrovascular accident (CVA) within 6 months;
- •Congestive heart failure (NYHA Class III and IV);
- •Uncontrolled hypertension;
- •Women of Child Bearing Potential
- •History of renal disease, peripheral vascular disease (PVD), pulmonary disease, gastrointestinal disease, active liver disease, or endocrine disease
结局指标
主要结局
The change from baseline in insulin medicated glucose disposal after 16 weeks of treatment with Muraglitazar
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
3 期
Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin AloneDiabetes Mellitus, Type 2NCT00095030Bristol-Myers Squibb1,752
已完成
3 期
Study of Muraglitazar Versus Pioglitazone in Type 2 DiabetesType 2 Diabetes MellitusNCT00106808Bristol-Myers Squibb1,440
已完成
3 期
Liraglutide in Adolescents With Type 1 DiabetesType 1 DiabetesNCT02516657University at Buffalo5
招募中
4 期
The Effects of Mirabegron and Tadalafil on Glucose Tolerance in PrediabeticsPre-diabetesObesityNCT05051436Philip Kern96
已完成
4 期
Liraglutide in Obesity and Diabetes: Identification of CNS Targets Using fMRIEffects of Liraglutide Administration on Brain ActivityWeight LossHungerDiabetesNCT01562678Beth Israel Deaconess Medical Center28